C. Difficile

The FDA has granted biopharmaceutical company, MGB Biopharma’s lead candidate, MGB-BP-3, Qualified Infectious Disease Product (QIDP) designation for the treatment of Clostridium difficile-associated Diarrhea.

A new study shows that detecting and isolating Clostridium difficile carriers when they are admitted to hospitals can significantly reduce the incidence of new infections from the pathogen.

In the battle against drug-resistant pathogens, genetic research holds promising answers to our toughest threats. A new study shows that the best tool for treating Clostridium difficile infections could be within the genome of the bacteria itself.

As the rise of antibiotic-resistant bacteria leads to higher rates of life-threatening infections from pathogens such Clostridium difficile and methicillin-resistant Staphylococcus aureus (MRSA), researchers are increasingly looking to probiotic treatment as an important part of fighting infections.

Robin Jump, MD, PhD, assistant professor in the Department of Medicine at the Case Western Reserve University discusses ways to improve infection control for C. difficile in healthcare facilities.

Robin Jump, MD, PhD, assistant professor in the Department of Medicine at the Case Western Reserve University, discusses how 'careful observation' can be used to decrease the number of unnecessary antibiotic prescriptions in the healthcare setting.

Robin Jump, MD, PhD, assistant professor in the Department of Medicine at the Case Western Reserve University, discusses efforts to screen asymptomatic Clostridium difficile carriers as well as some of the barriers to implementing active surveillance and putting asymptomatic carriers in isolation.

Robin Jump, MD, PhD, assistant professor in the Department of Medicine at the Case Western Reserve University, outlines ways that healthcare providers can improve the prevention and management of C. difficile in post-acute care facilities.

A new bacteriophage (phage) treatment-based approach to fighting Clostridium difficile (C. difficile) colonization and infection may one day provide for effective treatment against this potentially lethal disease.

A recent review article on the status of vaccines in development for healthcare associated infections (HAIs) provides both an in-depth discussion of their urgent need, as well as their potential for success.

Clostridium difficile infection (CDI) can be spread between facilities, particularly in older adults. One study has found that collaboration between facilities may help curb the spread of this potentially deadly infection.

Treatment with SER-109 is considered to be effective in treating Clostridium difficile infection.

Dorothy McCoy, PharmD, shares information on how to avoid a hospital acquired infection (HAI).

Dorothy McCoy, PharmD, describes what healthcare professionals can do to help avoid Clostridium difficile (C. diff) infections in their patients.

Dorothy McCoy, PharmD, explains why Clostridium difficile (C. diff) is so difficult to prevent.

US hospitals have made significant reductions in the incidence of hospital-acquired infections (HAIs) over the past decade, a new report from the Centers for Disease Control and Prevention (CDC) has revealed.

Clostridium difficile infections (CDI) have been a growing source of concern in healthcare as rates of recurrent infections are increasing in elderly populations and widespread antibiotic usage continues.

The student was diagnosed with Clostridium difficile infection (CDI) on February 7, 2016 at Liberty Elementary School of Broken Arrow, Oklahoma.

A survey of 571 US hospitals regarding practices used to prevent Clostridium difficile infection indicates that nearly half of the facilities appear to not be taking steps to prevent the infection that kills nearly 30,000 people and sickens hundreds of thousands more each year, despite strong evidence that these steps work.

From 2001 to 2010, the infection rate of a particular intestinal "superbug" has doubled, with increases in mortality rates and length of hospital stays reflecting this trend.